COURSE INFORMATION
Module Name | Monitoring Therapy and Drug Side Effects | |||
Module Level, if applicable | 4th year | Types of teaching and learning | Teaching & Group Discussion | |
Code, if applicable | SFA-987 | Class size | 50 & 50 | |
Semester | 7th semester | Attendance time (hours per week per semester) | 2h & 1h | |
Person responsible for the module | Dr. Apt. Vitarani Dwi Ananda Ningrum, M.Si | Forms of active participation | Lectures & Case-Studies And Report Writing | |
Lecturer(s) | Dr. Apt. Vitarani Dwi Ananda Ningrum, M.Si | Workload | Lecture: 2 (hour) x 14 (meeting) = 28
Preparation and follow up 4 (hour) x 14 (self-learning) = 56 Practical: 1 (Hours) X 12 (Meeting) = 12 Preparation And Follow Up: 2 (Hours) X 12 (Self-Preparation) = 24 |
|
Language | English- Indonesia | Total workload | 120 hours | |
Relation to curriculum | Elective Courses | Credit points | 3 CU |
REQUIREMENTS
Requirements according to examination regulations | Minimum Attendance At Lectures Is 75% (According To Uii Regulation). Final Score Is Evaluated Based On Assignment And Reports (40%), Mid Semester Exam (30%), And End Semester Exam (30%). |
Recommended prerequisites | Therapeutic Concepts |
Related course | – |
Study and examination requirements and forms of examination | Mid-Term, Final Term, Group Paper |
MODULE OBJECTIVES/INTENDED LEARNING
By the end of this course students should be able to:
- Understand and apply the attitude of responsibility,dedication, and disciplinary in carrying out lectures and completing well-given lecture assignments.
- Critically appraisal against various EBM drug side effects events correctly
- Distinguish between the responsibilities of the pharmaceutical industry and health workers in health facilities related to the safety of drug use
- Explain the definitions, objectives, and forms and parameters oftreatment therapy as part of the pharmacist’s responsibility in the field of services to support safe and effective treatment
- Distinguish between pharmacovigilance, drug side effects with adverse drug reaction and adverse event.
- Associate therapeutic monitoring and drug side effects in cases of real patients with nervous system disorders, gastrointestinal and respiratory diseases, diseases of the hormone-endocrine system, diseases/disorders of the renal-cardiovascular system, and infectious-malignant diseases.
CONTENT
The course will cover:
- Pharmaceutical care
- Pharmacovigilance
- Treatment therapy monitoring
- Drug Side Effects
- Real patient cases
MEDIA EMPLOYED
Slides (Power Points), And Video
READING LISTS
- Robert J. Cipolle, Linda M. Strand, Peter C. Morley , Pharmaceutical Care Practice: The Patient-Centered Approach to Medication Management Services, 3e, 2012, McGraw-Hill Medical
- https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3853665/
- https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3853674/
- Evidence Based Medicine – New Approaches and Challenges, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3789163/
- Various journal sites (www.nejm.org ; www.bmj.com journal ; www.cochrane.org; https://ebm.bmj.com/)